Literature DB >> 3291927

Tumour necrosis factor.

M K Brenner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3291927     DOI： 10.1111/j.1365-2141.1988.tb07615.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Combination of recombinant cytokines fails to produce ex vivo expansion of human blood hematopoietic progenitor cells.

Authors:  Y Takaue; T Abe; Y Kawano; A Hirao; A Yokobayashi; Y Okamoto; S Saito; T Shimizu; J Sato; T Watanabe
Journal:  Ann Hematol       Date:  1992-05       Impact factor: 3.673

2.  TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cells.

Authors:  R Munker; L Greither; M Darsow; S Pander; W Wilmanns
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

3.  Production of tumour necrosis factor by mastocytoma P815 cells.

Authors:  I Ohno; Y Tanno; K Yamauchi; T Takishima
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

4.  Tumor necrosis factor in benign and malign tissue of the kidney.

Authors:  K H Bichler; S Kleinknecht; H J Nelde; W L Strohmaier
Journal:  Urol Res       Date:  1991

5.  Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor.

Authors:  A Ferrante; B Hauptmann; P Seckinger; J M Dayer
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

6.  Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma.

Authors:  N Yoshida; S Ikemoto; K Narita; K Sugimura; S Wada; R Yasumoto; T Kishimoto; T Nakatani
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.